期刊文献+

降脂消斑片对动脉粥样硬化兔VEGF与主动脉病理变化的影响

Effects of Jiangzhi Xiaoban Pills on VEGF and the Aorta of Pathological Changes in Atherosclerotic Rabbits
下载PDF
导出
摘要 目的:观察降脂消斑片对动脉粥样硬化兔VEGF与主动脉病理变化的影响。方法:运用高脂高胆固醇饲料喂养12周以造成日本大耳白兔动脉粥样硬化模型,用降脂消斑片灌胃给药治疗4周,采用双抗体夹心酶联免疫吸附法检测血清中VEGF的含量,同时观察主动脉及粥样硬化斑块病理学改变。结果:与模型组比较,降脂消斑片能明显降低血清中VEGF的含量,差异有统计学意义(P<0.01);病理学结果显示,降脂消斑片干预后,主动脉粥样斑块面积减少、斑块厚度变薄,斑块较非干预组稳定。结论:降脂消斑片可以降低兔AS模型血清中VEGF的含量,减轻主动脉粥样硬化斑块及血管内膜的脂质浸润程度,稳定动脉粥样硬化斑块。 Objective: To observe the effects of Jiangzhi Xiaoban pills on VEGF and the aorta of pathological changes in atherosclerotic rabbits. Methods: High cholesterol diet was applied to induce the rabbit models for 12 weeks, with intragastric administration with Jiangzhi Xiaoban pills for 4 weeks;the serum levels of VEGF in the rabbits was detected by double antibody sandwich enzyme-linked immunosorbent method, and the aorta of pathological changes were observed in atherosclerotic rabbits. Results: Comparing with the model group, the Jiangzhi Xiaoban pills could decrease significantly the serum levels of VEGF, and the difference was statistically significant(P〈0.01);Pathology showed that the intervention of Jiangzhi Xiaoban pills decreased the area of atherosclerotic plaque and caused the plaque to thinner and stable. Conclusion: The Jiangzhi Xiaoban pills can inhibit the serum levels of VEGF, lessen the aorta of atherosclerotic plaque and the intimal of lipid infiltration, and stabilize the atherosclerotic plaques.
机构地区 湖南中医药大学
出处 《中医药导报》 2014年第11期6-9,共4页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 国家"十一五""重大新药创制"科技重大专项(2010ZX09101-103) 湖南省教育厅课题(编号为10C1053) 湖南中医药大学中医基础理论重点学科资助(200706)
关键词 降脂消斑片 动脉粥样硬化斑块 血管内皮生长因子 主动脉病理变化 Jiangzhi Xiaoban pills Atherosclerotic plaques VEGF The aorta of pathological changes
  • 相关文献

参考文献6

二级参考文献31

  • 1黑卫可,李娟.冠心病痰瘀证与血液流变性及血脂关系的研究[J].河南中医,1993,13(3):112-114. 被引量:18
  • 2李贵才,刘占军,徐德锌,高洪喜,刘秀霞,魏淑春.家兔动脉粥样硬化模型稳定性的观察[J].中国比较医学杂志,2004,14(5):294-297. 被引量:24
  • 3蒋卫东,曾季平,秦爱琼,鹿庆华,徐冬玲,葛志明.小干扰RNA对人内皮细胞株类表皮生长因子域7基因表达抑制作用的实验研究[J].中华心血管病杂志,2006,34(7):643-646. 被引量:3
  • 4邓次妮,沈潞华.一氧化氮合酶/一氧化氮系统与心血管疾病[J].心血管病学进展,2007,28(4):603-606. 被引量:38
  • 5[3]Toshima S,Hasegama A,Kurabayashi M,et al.Circulating oxidized low density lipoprotein.A biochemical risk marker for coronary heart disease.Arterioscler Thromb Vasc Bioj,2000,20(10):2243~2247.
  • 6[6]Devaraj S,Jialal L.Alpha toeopheml supplementation decreases serum C-reactive protein and monocyte imedeukin-6 levels in normal vdunteers and type2 diabetic patients.Free Radic BiolMed,2000,29(8):790~792.
  • 7[7]Kang E S,Kim H J,Kim Y M,et al.Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type2 diabetes.Diabetes Res Clin Pract,2004,66(1):115~120.
  • 8[8]Corrado E,RizzoM,Muratori I.Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in Patients with newly diagnosed hypertension or type Ⅱdiabetes.Arch Med Res,2006,37(8):1004~1009.
  • 9[9]Mita T,Watada H,Uchino H,et al.Association of C-reactive Protein with Early-stage Carotid Atherosclerosis in Japanese Patients with Early-state Type 2 Diabetes Mellitus.Endocr J,2006,53(5):693~698.
  • 10[11]Superko HR.The new thinking on lipid and coronaryartery disease.Curr Opin Cardiol,1997,12(2):180~187.

共引文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部